Intrinsiqs

Is Abbott Laboratories overvalued?

Abbott Laboratories (ABT) looks overvalued — trading about 63% above its fair value.

Overvalued
Current price $108.52 Fair value $40.45
Price
$108.52
Fair value
$40.45
Current P/E
29.2
Normal P/E
10.9
Market cap
$187.95B
Dividend yield
2.3%
Return on equity
9.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ABT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.